Together with our clinical partners, we’re working to redefine what’s possible in the field of organ technology. Doing that takes collaboration, knowledge sharing, and mutual support as we grow together with the common goal of saving lives through advances in organ care.
Led by Science. From the Start.
Co-Founder Prof. Peter Friend and colleagues publish the first NMP paper.
OrganOx is spun out independently from University of Oxford.
OrganOx begins product development on metra for liver.
OrganOx receives CE mark for the metra system.
OrganOx metra gains FDA approval for liver transplants in the U.S.
Our Heritage of Academic Rigor
The academic discipline we bring to our mission dates all the way back to our beginnings in the Innovation Lab at Oxford University. There, our co-founders combined their surgical and engineering expertise to focus on extracorporeal support for patients with liver disease.
Following where the science led, they developed a breakthrough solution:
The world’s first normothermic machine perfusion (NMP) device for liver transplantation1 was an achievement that changed the course of organ technology.
Today, as we continue to push the field of organ technology forward, the work of our founders is driven and amplified by an extraordinary leadership team, bringing together deep expertise in healthcare, engineering, and medical technology.
Keep up to date with the latest OrganOx updates and recent news in organ transplantation.